CCSD code 25160 – Trigeminal ganglion radiofrequency lesion

Key takeaways

CCSD code 25160 describes a percutaneous trigeminal ganglion radiofrequency lesion under X-ray control, not a peripheral nerve block or injection.

Fluoroscopic guidance is part of the procedure definition, so claims without operative-note confirmation of imaging are routinely denied.

G50.0 (Trigeminal neuralgia) is the primary ICD-10 diagnosis code, and a missing or mismatched code triggers insurer queries.

Prior authorization is required by all major UK private insurers before the procedure, and post-procedure requests are rarely accepted.

Pabau’s claims management software lets UK private practice teams attach ICD-10 codes, flag prior-auth status, and submit CCSD-coded invoices electronically.

CCSD code 25160: Definition and official descriptor

CCSD code 25160 is the procedure code for a trigeminal ganglion radiofrequency lesion (under X-ray control). It is defined by the Clinical Coding and Schedule Development (CCSD) Group, which maintains the procedure code schedule used by UK private medical insurers.

The descriptor is precise. The procedure must target the trigeminal (Gasserian) ganglion specifically, and it must use a radiofrequency electrode to create a controlled thermal lesion.

It must also be performed under real-time X-ray (fluoroscopic) guidance. Balloon compression of the ganglion and destruction of a peripheral trigeminal branch carry their own codes and their own documentation requirements.

How a percutaneous radiofrequency trigeminal rhizotomy is performed

A percutaneous radiofrequency trigeminal rhizotomy is a minimally invasive neurosurgical procedure. It uses controlled heat to damage the pain fibers at the Gasserian ganglion. Knowing the technique matters here because the operative note has to describe it accurately for the claim to be paid.

1. Patient positioning and fluoroscopy set-up. The patient lies supine. The fluoroscopy unit is positioned to visualize the skull base and foramen ovale before needle insertion begins.
2. Percutaneous needle placement. Under continuous fluoroscopic guidance, a radiofrequency cannula is advanced through the cheek and the foramen ovale to the Gasserian ganglion. Fluoroscopy confirms the needle tip position at each stage.
3. Impedance and sensory testing. With the patient awake, low-current stimulation confirms the electrode sits beside the correct trigeminal division (V1, V2, or V3). It does this by reproducing the patient’s typical facial pain or paresthesia.
4. Brief general anesthetic (GA). A short-acting intravenous agent renders the patient unresponsive for the thermal lesioning phase, which stops involuntary movement while the heat is applied.
5. Radiofrequency lesioning. The generator delivers controlled thermal energy, typically 60-90 degrees Celsius for 60-90 seconds per published neurosurgical technique, creating a focal lesion in the pain-carrying fibers.
6. Recovery and assessment. The brief GA is reversed and the patient is assessed for sensory deficit and any immediate complications. Discharge usually follows the same day or the next morning.

Each of these steps must be reflected in the operative note to satisfy insurer documentation requirements. A note describing “radiofrequency treatment to the trigeminal nerve” leaves out too much.

Without confirmation of fluoroscopic guidance, electrode positioning at the ganglion, and lesioning parameters, the insurer has grounds to query or downcode the claim.

Clinical indications for radiofrequency ablation of trigeminal neuralgia

Radiofrequency ablation for trigeminal neuralgia is a second-line treatment. UK private insurers expect evidence that the patient has already failed conservative management before they approve CCSD code 25160. The recognized indications are:

• Classical trigeminal neuralgia (tic douloureux) refractory to medical therapy. Typically after documented failure of carbamazepine or oxcarbazepine at therapeutic doses.
• Patients unsuitable for open microvascular decompression. Elderly patients, or those with significant comorbidities where craniotomy risk is unacceptable.
• Recurrent trigeminal neuralgia. Including recurrence after a prior percutaneous procedure or after previous microvascular decompression.
• Secondary trigeminal neuralgia. Where MS-related or post-herpetic facial pain is the underlying cause and medical therapy has failed.

The prior-authorization documentation submitted to the insurer should make at least one of these indications explicit. A submission citing “facial pain” without the trigeminal neuralgia diagnosis or the treatment history is a reliable route to a pre-approval delay or a refusal.

The role of X-ray (fluoroscopic) control in how this code is billed

Fluoroscopy belongs to the procedure definition in CCSD code 25160. The X-ray control phrase in the official descriptor means real-time intraoperative fluoroscopic guidance. It confirms needle placement through the foramen ovale and at the Gasserian ganglion. Perform the procedure without it and the work no longer matches what 25160 describes.

Two billing consequences follow. First, where fluoroscopy was not used and not documented, the procedure cannot legitimately be coded as 25160. The consultant then needs to find the CCSD code that describes the work performed.

Second, insurers may treat an unstated imaging step as an absent one. The note should record that “real-time fluoroscopic guidance was used throughout needle insertion and positioning” rather than leaving it implied.

Whether fluoroscopy can be billed separately alongside CCSD code 25160 depends on the individual insurer contract. The CCSD schedule generally bundles intraoperative imaging within the procedural code, but specific insurer fee agreements vary. Check the relevant insurer’s billing guide before submitting a separate imaging charge.

Correct ICD-10 diagnosis codes to pair with CCSD code 25160

Every CCSD-coded claim submitted to a UK private insurer requires a paired ICD-10 diagnosis code. For CCSD code 25160, the primary code is G50.0 (Trigeminal neuralgia). Submitting without a diagnosis code, or with a mismatched one, is a leading cause of claim rejection. The table below covers the primary and most common secondary codes.

One point catches out practices that work across both markets. UK insurers use the World Health Organization ICD-10, where post-herpetic facial pain sits at B02.2. The five-character codes in the US clinical modification, such as B02.22, belong to ICD-10-CM and are not used on UK private claims.

Laterality matters too. When the procedure is performed on the left or right side, the operative note and discharge summary should specify the side clearly. Some insurers flag claims where the documented side differs from prior imaging or referral letters in the patient’s file.

Neighboring CCSD codes: Knowing the differences

CCSD code 25160 belongs to a small group of procedures used to treat trigeminal neuralgia. Picking the wrong code from that group is a frequent error, partly because the codes do not run in a tidy numeric sequence. The table below compares the ones most often confused.

Only 25150 and 25160 sit next to each other in chapter 3 of the schedule. Branch destruction and balloon compression carry AA-prefixed codes, and open microvascular decompression is coded as a cranial nerve decompression. Check the current schedule before you submit, because CCSD revises code numbers between annual editions.

Documentation requirements for a valid CCSD code 25160 claim

A claim for CCSD code 25160 needs specific documentation at each stage of the patient pathway. Digital forms help here, especially when several team members contribute to one patient record. The required elements are:

• Pre-procedure insurer authorization reference. The authorization number must appear on the invoice. Claims submitted without a valid reference are rejected at triage, before any clinical review.
• Operative note confirming fluoroscopic guidance. It must state explicitly that real-time X-ray guidance was used. Record the approach through the foramen ovale, the electrode position, and that the ganglion was targeted.
• Lesioning parameters. Record the temperature in degrees Celsius and the duration in seconds. These figures are the objective evidence that a thermal lesion was created rather than a simple nerve block.
• Anesthetic record. Confirming the brief GA given for the lesioning phase, the agent used, and that the patient was awake for sensory testing.
• Laterality statement. The operative note and discharge summary must agree on which side was treated. Left and right discrepancies generate queries.
• Discharge summary with diagnosis code. It should carry the ICD-10 code (G50.0 or an appropriate variant) and a brief statement of clinical indication, confirming failed prior medical management.

Those six elements are created at four different moments by three different people, which is why they go missing. Mapped against the stage each one belongs to, the claim reads as a single chain. Each link then carries its own denial reason.

Building these checks into the post-procedure step, before the invoice is generated, is what keeps the chain intact. Chasing an anesthetic record or a set of lesion parameters after the patient has gone home adds weeks. Insurers query an incomplete file.

Prior authorization for neurosurgery in the UK: What private insurers require

UK private insurers treat CCSD code 25160 as an elective neurosurgical procedure requiring pre-procedure authorization. Post-procedure requests are unlikely to succeed. The requirements are broadly consistent across major PMI payers, though each insurer runs its own forms and processes.

The typical insurer evidence pack for a CCSD code 25160 authorization request includes:

• Referring clinician letter. From a neurologist or neurosurgeon confirming the TN diagnosis and treatment history. GP-only referrals are often insufficient for a procedure at this level.
• Evidence of failed medical therapy. Documentation showing carbamazepine or oxcarbazepine was trialed at therapeutic doses and either failed to control pain or caused unacceptable side effects. Dates and doses strengthen the submission.
• MRI head or skull base imaging. To exclude structural causes such as a tumor or vascular malformation, and to show the clinical workup has been completed.
• Consultant assessment letter. From the neurosurgeon or pain specialist, confirming the indication for a percutaneous procedure and the patient’s suitability for it.
• Insurer-specific authorization form. Bupa, AXA Health, Aviva, and Vitality each run their own online portals. The reference each one issues must be captured in the practice management system before the procedure date.

Facility registration matters at this stage too. Insurers may ask for confirmation that the site is registered with its regulator before they approve procedures there, as part of their credentialling checks.

CCSD code 25160 fee schedule and reimbursement

CCSD code 25160 sits in chapter 3 of the CCSD schedule, covering the spine, spinal cord and peripheral nerves. Actual reimbursement is set by each insurer’s own fee schedule, agreed contractually with recognized consultants.

The Bupa CCSD fee schedule and the equivalent documents from AXA Health and Aviva are the operative references for payment amounts.

Complexity banding is worth checking separately, and it surprises people. CCSD owns the code and its narrative, but it does not set fees or complexity, so each insurer bands the code itself.

Bupa’s own CCSD reference puts 25160 in Major 2, while Freedom Health Insurance’s Freedom Elite schedule bands it as Intermediate. Same procedure, same descriptor, two different bands and two different fees.

Additional codes typically submitted alongside CCSD code 25160 in a single episode include:

For published fee information, the Aviva fee schedule and the Vitality Health fee finder both let recognized consultants look up CCSD reimbursement amounts directly.

Common CCSD code 25160 claim denials and how to avoid them

Claims for CCSD code 25160 fail for predictable reasons. The table below maps the most common denial triggers to their prevention actions. If you want the wider picture, the same patterns show up across the common denial codes used throughout medical billing.

Unbundling and add-on code considerations

Unbundling errors occur when a practice separately bills a component that the primary code already includes, producing an invoice that overstates what was done. For CCSD code 25160, the main unbundling risk concerns intraoperative fluoroscopy.

As the fee schedule section above sets out, separate billing for fluoroscopy is insurer-specific. The Healix fee schedule gives detailed unbundling guidance for CCSD codes, and other insurers publish equivalent rules in their provider billing manuals. When in doubt, do not submit a separate imaging charge without confirming the insurer’s position in writing.

What can be billed alongside CCSD code 25160 without unbundling concerns:

• Anesthesia codes. The brief GA is performed by a separate anesthetist and billed on a separate invoice. Different practitioners deliver the two services, so this is not an unbundling issue.
• Facility and theatre codes. Billed by the independent hospital rather than the consultant surgeon. Again, a separate invoice from a separate entity.
• Pre-procedure outpatient consultation. Where the patient attended a separate appointment before the procedure date, that consultation is billed using the appropriate outpatient CCSD code. Under most insurer contracts it only becomes unbundling when claimed on the day of the procedure.

Billing CCSD code 25160 in practice management software

Most practices still assemble a 25160 claim after the fact. The authorization number sits in an email and the operative note sits in the clinical system. Days later, the billing team reconstructs the episode from both. That is where the fluoroscopy statement and the lesion parameters go missing.

Practice management software like Pabau holds the episode together instead. The claims management software keeps the CCSD code, the ICD-10 pairing, the authorization reference, and the supporting documents on one record. Your billing team can therefore raise the invoice from the record itself, rather than chasing three systems for the evidence.

For every 25160 episode, the workflow runs like this:

1. Add the procedure code. Search for 25160 in the CCSD code library. Confirm the descriptor reads “Trigeminal ganglion radiofrequency lesion (under X-ray control)” before selecting it.
2. Attach the ICD-10 diagnosis code. Add G50.0 as the primary diagnosis. Where secondary codes such as G35 or B02.2 apply, add those in the secondary fields on the same episode record.
3. Record the prior-authorization number. Enter the insurer-issued reference in the designated field, and flag the record so no invoice can be generated until that reference is present.
4. Attach supporting documentation. Link the operative note, anesthetic record, and discharge summary to the episode before submission. Some insurers request these upfront, others on query.
5. Submit electronically to the insurer. The insurer’s preferred electronic route cuts processing time and creates a traceable submission record.

Standardizing those five steps at the point of discharge, rather than leaving them to the billing team days later, cuts the rate of missing-documentation queries. Everything the insurer might ask for already sits on the patient record, so nobody is searching for it after the fact.

Submit CCSD-coded claims with fewer rejections

Pabau helps UK private practices attach ICD-10 codes and manage prior-authorization references. CCSD-coded invoices go out electronically to Bupa, AXA Health, Aviva, and other major PMI payers. Book a demo to see how it works for neurosurgery and pain teams.

Book a demo

Conclusion

Nothing about CCSD code 25160 is ambiguous at the coding level. The descriptor names the target, the mechanism, and the imaging, and G50.0 is the diagnosis in almost every case.

What decides payment is whether five documents still agree with each other by the time the invoice goes out. Three people create them across four separate moments.

So treat this code as a records problem rather than a coding one. Capture the authorization number at booking and write the fluoroscopy statement into your operative note template. Then hold the discharge summary until the side and the diagnosis code match. The trade-off is a few minutes of structure per episode against a denial cycle that runs four to six weeks.

Get that discipline into the system your team already works in and it stops depending on anyone remembering. Book a demo to see how Pabau keeps the operative note, the authorization reference, and the CCSD-coded invoice on one patient record.

Continue your research

Need a broader reference for Bupa CCSD billing? Bupa CCSD procedure codes covers the full CCSD code set as Bupa uses it, with guidance on code selection and submission.

Looking up a different CCSD code? CCSD codes is the index of every CCSD billing guide on the site, grouped by chapter.

Billing another image-guided pain procedure? 25120 covers the dorsal root ganglion block, which sits in the same chapter and carries similar imaging documentation rules.

Frequently asked questions